Subscribe to newsletter
Facebook
Linkedin
X
Youtube
Linkedin
Twitter
Youtube
Sat 8 August 2026
Subscribe to DDD newsletter
Search
Drug Discovery and Development
Drug Discovery
IND
Phase 1-2 trials
Phase 3 trials
Approvals
Finance
Conferences
Journal
Drug Discovery
IND
Phase 1-2 trials
Phase 3 trials
Approvals
Orexo announces positive outcome from in vivo study of OX390
19 June 2026
MEKanistic Therapeutics announces FDA clearance of IND for MTX-531, enabling phase 1 trials in advanced solid tumours
19 June 2026
Matter Bio files first IND for Lm-LLO-TT, advancing first-in-human phase 1/2a study in patients with pancreatic cancer
19 June 2026
Myosin Therapeutics initiates phase 1/2 trial of MT-125 targeting non-muscle myosin II in newly diagnosed glioblastoma
19 June 2026
New clinical study shows pasteurised Akkermansia muciniphila MucT supports weight loss maintenance
19 June 2026
Products
CDMO
CRO
Tags
FDAapproval
Tag:
FDAapproval
FDA grants approval for a gene therapy to treat rare genetic disease
Louise Wilson-English
-
1 March 2026
0
Most Read
Orexo announces positive outcome from in vivo study of OX390
19 June 2026
MEKanistic Therapeutics announces FDA clearance of IND for MTX-531, enabling phase 1 trials in advanced solid tumours
19 June 2026
Matter Bio files first IND for Lm-LLO-TT, advancing first-in-human phase 1/2a study in patients with pancreatic cancer
19 June 2026
Myosin Therapeutics initiates phase 1/2 trial of MT-125 targeting non-muscle myosin II in newly diagnosed glioblastoma
19 June 2026